RadNet

RadNet, Inc. (Nasdaq: RDNT) is the leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the US based on the number of locations and annual imaging revenue. The company was founded in 1981 and went public in 1992 through a merger with Primedex Health Systems.

RadNet operates a network of 366 owned and/or operated outpatient imaging centers across markets including California, Maryland, Delaware, New Jersey, New York, Florida, Arizona, and most recently Texas. The company provides a wide range of imaging services, including:

• MRI

• CT

• PET/CT

• X-ray

• Ultrasound

• Mammography

• Nuclear medicine

RadNet has focused on growth through expanding existing centers, opening new locations, and strategic acquisitions. The company has also established joint ventures and partnerships with hospital systems to expand its network.

In recent years, RadNet has made significant investments in artificial intelligence and digital health technologies. The company acquired AI companies DeepHealth, Aidence, and Quantib to develop AI solutions for breast, lung, and prostate cancer screening. In 2024, RadNet formed a new Digital Health reporting segment combining its software/informatics businesses with its AI operations. The company expects its AI revenue to grow over 65% in 2024 compared to 2023. RadNet is also investing in cloud-based software solutions and generative AI to improve operational efficiency.